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Abstract
In this paper, the metabolic activity in single and dual species biofilms of Staphylococcus
epidermidis and Staphylococcus aureus isolates was investigated. Our results demon-
strated that there was less metabolic activity in dual species biofilms compared to S. aureus
biofilms. However, this was not observed if S. aureus and S. epidermidis were obtained
from the same sample. The largest effect on metabolic activity was observed in biofilms of
S. aureus Mu50 and S. epidermidis ET-024. A transcriptomic analysis of these dual species
biofilms showed that urease genes and genes encoding proteins involved in metabolism
were downregulated in comparison to monospecies biofilms. These results were subse-
quently confirmed by phenotypic assays. As metabolic activity is related to acid production,
the pH in dual species biofilms was slightly higher compared to S. aureus Mu50 biofilms.
Our results showed that S. epidermidis ET-024 in dual species biofilms inhibits metabolic
activity of S. aureus Mu50, leading to less acid production. As a consequence, less urease
activity is required to compensate for low pH. Importantly, this effect was biofilm-specific.
Also S. aureus Mu50 genes encoding virulence-associated proteins (Spa, SplF and Dps)
were upregulated in dual species biofilms compared to monospecies biofilms and using
Caenorhabditis elegans infection assays, we demonstrated that more nematodes survived
when co-infected with S. epidermidis ET-024 and S. aureus mutants lacking functional spa,
splF or dps genes, compared to nematodes infected with S. epidermidis ET-024 and wild-
type S. aureus. Finally, S. epidermidis ET-024 genes encoding resistance to oxacillin, eryth-
romycin and tobramycin were upregulated in dual species biofilms and increased resistance
was subsequently confirmed. Our data indicate that both species in dual species biofilms of
S. epidermidis and S. aureus influence each other’s behavior, but additional studies are
required necessary to elucidate the exact mechanism(s) involved.
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Introduction
Staphylococcus aureus is an important nosocomial pathogen [1] and infections caused by S.
aureus range from skin infections to systemic infections [2). The success of S. aureus as a path-
ogen can partially be attributed to its antibiotic resistance and to its ability to form biofilms [3–
5]. Also, the production of a wide range of virulence factors enables S. aureus to cause infec-
tions [4,6,7]. For instance, Staphylococcus protein A (SpA) contributes to the onset and severity
of S. aureus infections [8–11]. Exoenzymes (including SplF proteases) can degrade host pro-
teins or interfere with host signaling cascades [6,12] while Dps proteins (homologs of MrgA in
Bacillus subtilis) play a role in infections by conferring resistance to nitric oxide and hydrogen
peroxide [13,14]. These Dps proteins are usually described as Dps homologues to the Escheri-
chia coli Dps proteins. In S. aureus this homologue has originally been described as MrgA
(Metallo regulon gene A) in analogy to Bacillus subtilis [15].
Staphylococcus epidermidis is a commensal organism but can also cause device-related infec-
tions [2,16,17]. The ability of S. epidermidis to form biofilms is an important virulence factor
[18]. Furthermore, S. epidermidis can act as a reservoir of antibiotic resistance genes for S.
aureus [19,20]. A large fraction of clinical S. epidermidis isolates showed resistance to different
antibiotics including β-lactams (e.g. methicillin resistance encoded by mecA), macrolides (e.g.
erythromycin resistance encoded by ermABC) and aminoglycosides (e.g. tobramycin resis-
tance encoded by aacA-aphD) [21–23].
The role of multispecies biofilms in device-related infections is not yet completely under-
stood but several papers already reported that S. aureus and S. epidermidis are often co-isolated
from biofilms present on indwelling medical devices [24–26].
Several studies focused on the gene expression in S. aureus biofilms. For instance, Resch
et al. (2005) compared gene expression levels of planktonic S. aureus cultures to those in bio-
films. Urease genes and genes encoding proteins involved in formate synthesis were upregu-
lated in biofilms compared to planktonic cells and it was suggested that urease activity
protected the cells by counteracting the low pH (resulting from formate metabolism) [5]. In
general, urease activity protects bacteria in acidic environments by neutralizing acids [27]. For
instance, it was already reported that treating S. aureus cultures with acids resulted in an upre-
gulation of urease activity [28]. Urease (urea amidohydrolase) catalyzes the hydrolysis of urea,
leading to two molecules of ammonia and one molecule of carbon dioxide in aqueous environ-
ments [29,30]. Urease enzymes are structurally complex, containing an apoenzyme (α, β and
γsubunits encoded by ureABC) and accessory proteins (encoded by ureDEFG) [26,29,30].
In the present study, we have determined the metabolic activity in single and dual species
biofilms formed by various S. aureus and S. epidermidis strains. Subsequently, we performed a
transcriptome analysis of single and dual species biofilms of S. epidermidis ET-024 and S.
aureus Mu50 (the pair of strains for which the largest effect on metabolic activity was
observed). We then set out experiments to confirm several of the observations made during
the transcriptomic analysis.
Materials and methods
Strains
S. epidermidis ET-024 was isolated from an endotracheal tube (ET) biofilm of a mechanically
ventilated patient [24] while S. aureus Mu50 was isolated from an infected wound of an infant
[31]. S. aureus ET-058 and S. epidermidis ET-059 were isolated from the same ET biofilm, as
were S. aureus ET-106/S. epidermidis ET-107, S. aureus ET-131/S. epidermidis ET-130 and S.
aureus ET-181/S. epidermidis ET-167 [32]. Also, five additional S. aureus reference strains
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were included: S. aureus JE2, S. aureus LMG 8224, S. aureus ATCC 6538P, S. aureus LMG
10147 and S. aureus Newbould305 [33–36]. Pure cultures were made on Mueller Hinton Agar
(MHA; 24 hours at 37˚C). S. aureus JE2 transposon mutants (NARSA; Network on Antimicro-
bial Resistance of Staphylococcus aureus) lacking functional spa (NE286), splF (NE1764) or dps
(NE1929) genes were used to infect C. elegans. These isolates were grown (24 hours, 37˚C) on
MHA containing 5 μg/ml erythromycin [37]. All strains were stored at -80˚C using the Micro-
Bank System (Pro-Lab Diagnostics, Neston, UK).
Biofilm formation
Overnight cultures of S. epidermidis ET-024 and S. aureus Mu50 were diluted to approx. 5 x
107 colony forming units (CFU)/ml (for monospecies biofilms) or to approx. 108 CFU/ml (for
dual species biofilms; equal volumes of both cultures were subsequently mixed). For plank-
tonic cultures, 5 ml of diluted cell suspensions was transferred to falcon tubes and incubated in
a shaking warm water bath (24 hours, 37˚C).
For biofilm formation we used the approach described by Peeters et al. (2008) [38] and
100 μl of diluted cells suspensions were transferred to the wells of a 96 well microtiter plate
(MTP); two rows served as blanks. After 4 hours at 37˚C, all wells were rinsed with 100 μl of
physiological saline (PS; 0.9% NaCl) and 100 μl of MHB was added (20 additional hours of
incubation at 37˚C). In all dual species biofilms experiments described in this study, we have
used 1:1 ratios of S. aureus and S. epidermidis strains. In order to test the relative fitness of S.
aureus and S. epidermidis, we have also performed biofilm experiments with different ratios of
S. aureus Mu50 and S. epidermidis ET-024 cells (i.e. 1/1, 1/10 and 10/1). After incubation, cells
were removed from the wells by two rounds of sonication (5 min) and vortexing (600 rpm; 5
min). Serial dilutions (10−1 to 10−8) were made and plated on MHA (24 hours at 37˚C). After
counting the colonies, the number (log10) of CFU per biofilm was determined. Also, the bio-
film forming capacities of strains investigated in this study were evaluated by a crystal violet
assay.
The pH of single and dual species biofilms of S. epidermidis ET-024 and S. aureus Mu50 was
measured after 24 hours incubation at 37˚C. To do this, biofilms were grown in a 24 well MTP
(1 ml of cell suspension per well) and after 4 hours of incubation, the wells were rinsed and 1
ml of MHB was added (20 additional hours of incubation at 37˚C).
Determination of metabolic activity
The metabolic activity of S. aureus and S. epidermidis in single and dual species biofilms (96
well MTP) was determined by a resazurin-based assay. After incubation, biofilms were rinsed
and 120 μl of a resazurin solution (Promega, Leiden, The Netherlands) was added to each well.
The MTP was incubated for 20 min at 37˚C and afterwards, the fluorescence (excitation wave-
length: 560 nm; emission wavelength: 590 nm) was measured (Envision, PerkinElmer, Zaven-
tem, Belgium). The values were normalized to the number (log10) of CFU per biofilm.
pH measurements of single and dual species biofilms of S. epidermidis
ET-024 and S. aureus Mu50
After incubation, the biofilm supernatant was collected and subsequently centrifuged to
remove all cells. The obtained supernatant was again added to the biofilms and the biofilm
cells were suspended. The pH of these suspensions was measured (3 biological replicates)
using a pH probe (Hanna Instruments, Temse, Belgium).
Dual species biofilms of S. aureus and S. epidermidis
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RNA extraction of single and dual species cultures of S. epidermidis ET-
024 and S. aureus Mu50
Three biological replicates were included. Planktonic cultures of S. aureus Mu50 and S. epider-
midis ET-024 were centrifuged for 5 min at 5000 rpm and the cell pellets were rinsed with 5 ml
RNAlater (Ambion, Life Technologies, Ledeberg, Belgium). For the biofilms, all wells of the
MTP were rinsed with 100 μl of RNAlater. Afterwards, 100 μl of RNAlater was added to all
wells and the cells were removed from the wells as described above. Subsequently, biofilm cells
were collected in a falcon tube and this procedure was repeated. Thereafter, the tubes were
centrifuged for 5 min at 5000 rpm and the cell pellet was rinsed with 5 ml of RNAlater. The
RiboPure RNA purification Bacteria kit (Ambion, Life Technologies) was used according to
the manufacturer’s instructions and the RNA solution was stored at -80˚C.
RNA-Seq on single and dual species biofilms of S. epidermidis ET-024
and S. aureus Mu50
Three biological replicates per sample were sequenced. Approximately 30 ng of rRNA depleted
RNA was used to create barcoded strand specific cDNA sequencing libraries with TruSeq
stranded library preparation kit (Illumina, San Diego, CA, USA). The libraries were equimo-
larly pooled and sequenced using a HiSeq (Illumina), generating unpaired reads of 100 bp.
After sequencing, the data were demultiplexed and the CLC Genomic Workbench 8.5.1 (Qia-
gen, Aarhus, Denmark) was used for analysis.
Initial quality control (based on length and Phred scores) resulted in more than 10,000,000
reads per sample. Reads were mapped to S. aureus Mu50 [30] and S. epidermidis ET-024
genomes [39] using stringent mapping conditions i.e. reads must map to the entire gene
sequence with 100% similarity and no mapping to the flanking regions was allowed. Reads per
kb per million (RPKM) expression values were calculated and the p value was determined
using edgeR statistics. The full transcriptomic dataset was deposited in the Gene Expression
Omnibus (www.ncbi.nlm.nih.gov/geo)—accession number GSE 79575.
qPCR analysis of urease coding genes
Prior to qPCR, RNA was converted to cDNA using the qScript cDNA SuperMix (Quanta Bio-
Sciences, Beverly, MA, USA) using the manufacturer’s instructions.
Species-specific primers targeting the urease genes of S. aureus Mu50 and S. epidermidis
ET-024 were developed S1 File). The expression values of S. aureus Mu50 and S. epidermidis
ET-024 urease genes were normalized by the expression values of selected reference genes. We
used publically available primer sequences [40] and newly designed species-specific primers
(Table A in S1 File).
qPCR reactions were carried out using the Bio-Rad real time PCR detection CFX-96 appa-
ratus (Bio-Rad) and PerfeCTa SYBR Green FastMix (Quanta BioSciences) according the man-
ufacturer’s instructions. Following PCR, the melting curves were determined by increasing the
temperature from 65˚C to 95˚C in steps of 0.5˚C (each for 5 s).
Determination of urease activity
Urease activity in single and dual species biofilms was measured using the urease activity assay
kit (Sigma-Aldrich, Bornem, Belgium). Biofilms were grown in a 96 well MTP and afterwards,
biofilm cell suspensions were collected. After centrifugation at 13000 rpm for 5 min, cell pellets
were resuspended in assay buffer and urease activity was determined according to the manu-
facturer’s instructions. The absorbance at 670 nm (A670) was measured (Tecan, Ma¨nnedorf,
Dual species biofilms of S. aureus and S. epidermidis
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Switzerland) and the urease activity (units/L) was calculated according to the manufacturer’s
instructions. The values were normalized to the number (log10) of CFU per biofilm.
Exposing biofilms to antibiotics
Minimal inhibitory concentrations (MIC) of oxacillin, erythromycin and tobramycin for S.
epidermidis ET-024 and S. aureus Mu50 were determined according to the CLSI guidelines
and S. aureus LMG 10147 was included as a reference strain.
After 4 hours of incubation, single and dual species biofilms were exposed to 4 μg/ml of
oxacillin, 2 μg/ml of erythromycin and 16 μg/ml of tobramycin. The plates were incubated for
20 additional hours at 37˚C and afterwards, serial dilutions (10−1 to 10−8) were made and inoc-
ulated on MHA supplemented with oxacillin (4 μg/ml), erythromycin (2 μg/ml) or tobramycin
(16 μg/ml). Plates were incubated for at least 24 hours (37˚C) and afterwards, the number
(log10) of CFU of S. aureus Mu50 and S. epidermidis ET-024 per biofilm was determined.
C. elegans infection assay
C. elegans strain N2 (of which glp-4 and sek-1 genes were deleted) was used [41, 42] and worms
were grown as previously described [39].
The effect on survival of C. elegans after infection with S. epidermidis ET-024, S. aureus
Mu50, S. aureus JE2 and NARSA mutants lacking a functional spa (NE286), splF (NE1764) or
dps (NE1929) gene, was evaluated. Prior to the actual experiments, the C. elegans assay was val-
idated and found to be a good system to test virulence of the NARSA mutants (S1 File). The
infection assay was performed in a 96 well MTP and approx. 30 L4 stage worms were added
per well in medium containing 95% M9 buffer (3 g KH2PO4, 6 g Na2HPO4, 1 ml 1 M MgSO4
per liter), 5% Brain Heart Infusion Broth (Lab M Limited, Heywood, UK) and 0.1 v/v % of a 5
mg/ml cholesterol solution (Sigma-Aldrich). Worms were infected by adding 25 μl of a bacte-
rial cell suspension (approx. 109 CFU/ml). Medium was added to a final volume of 100 μl per
well. The MTP was incubated (25˚C) and scored for live and dead worms after 48 hours of
infection (post infection; p.i.).
The number (log10) of CFU per nematode was determined as described by Brackman et al.
[43] and the dilutions were inoculated on MHA supplemented with 7.5% NaCl. Plates were
incubated (37˚C) for at least 24 hours and subsequently, the number (log10) of CFU per worm
was determined.
Statistical analysis
Statistical analysis was performed using the Mann-Whitney U test or the Kruskall-Walis test
(SPSS, version 23.0, Chicago, IL, USA). p values smaller than 0.01 were considered as statisti-
cally significant.
Results
Metabolic activity in single and dual species biofilms
In order to test the relative fitness, we have performed biofilm experiments with different
ratios of S. aureus Mu50 and S. epidermidis ET-024 (i.e. 1/1; 1/10 and 10/1). The results showed
that the initial ratios of both species are approx. maintained throughout the experiment. So,
there is no effect of one species on the survival of the other species. Also, the results of the crys-
tal violet assay demonstrated that all strains were able to form biofilms; the strongest biofilm
forming strains are the S. aureus reference strains (i.e. Mu50, LMG 8224, LMG 10147, New-
bould and ATCC 6538P) (Table C in S1 File).
Dual species biofilms of S. aureus and S. epidermidis
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The metabolic activity in single and dual species biofilms of S. aureus and S. epidermidis iso-
lates was normalized to the number of CFU per biofilm (see Table B in S1 File).
The metabolic activity in dual species biofilms of S. epidermidis ET isolates (i.e. ET-024, ET-
059, ET-107, ET-130 and ET-167) and S. aureus reference strains (i.e. Mu50, LMG 8224, LMG
10147, Newbould 305, JE2 and ATCC 6538P) was significantly lower than the metabolic activ-
ity in monospecies biofilms formed by these S. aureus reference strains (Fig 1A). However, the
metabolic activity of these dual species biofilms is similar (p> 0.01) to the metabolic activity
in biofilms formed by S. epidermidis ET isolates alone (Fig 1A).
We also investigated the metabolic activity in single and dual species biofilms formed by S.
aureus and S. epidermidis isolates both obtained from ET biofilms. We observed that the meta-
bolic activity of dual species biofilms formed by S. aureus ET isolates (i.e. ET-058, ET-106, ET-
131 and ET-181) and S. epidermidis ET isolates (i.e. ET-024, ET-059, ET-107, ET-130 and ET-
167) is significantly lower than the metabolic activity in monospecies biofilms formed by S.
aureus ET isolates (Fig 1B–1E). However, this effect was not observed if S. aureus and S. epider-
midis were obtained from the same ET biofilm (Fig 1B–1E), e.g. the metabolic activity in dual
species biofilms formed by S. aureus ET-058 and S. epidermidis ET-059 was similar to the met-
abolic activity in S. aureus ET-058 biofilms. Also, the metabolic activity in dual species biofilms
of S. aureus and S. epidermidis ET isolates is similar to the metabolic activity in monospecies
biofilms formed by these S. epidermidis isolates.
Based on these results, we decided to perform a transcriptome analysis (using RNA-Seq
and qPCR) on single and dual species biofilms of S. aureus Mu50 and S. epidermidis ET-024,
the pair for which the largest effect on metabolic activity was observed (Fig 1A).
Measuring the pH of single and dual species biofilms of S. epidermidis
ET-024 and S. aureus Mu50
At the start of incubation, the pH of the diluted cell suspensions used for biofilm formation of
S. aureus Mu50, S. epidermidis ET-024, and the dual species biofilm was very similar:
7.12 ± 0.02 (dual species biofilms), 7.20 ± 0.01 (S. epidermidis ET-024 biofilms) and 7.17 ± 0.03
(S. aureus Mu50 biofilms). After 24 hours of incubation, the pH of S. aureus Mu50 biofilms
was significantly (p< 0.01) lower (6.61 ± 0.01) than the pH of S. epidermidis ET-024 biofilms
(7.12 ± 0.02) and that of dual species biofilms (7.09 ± 0.02).
Transcriptomic analysis
The results of the RNA sequencing showed that 89 genes (59 of S. aureus Mu50 and 30 of S.
epidermidis ET-024) were significantly (p< 0.01) downregulated in dual species biofilms com-
pared to monospecies biofilms (with the fold change being at least two). In contrast, 134 genes
(51 of S. aureus Mu50 and 83 of S. epidermidis ET-024) were significantly upregulated in dual
species biofilms compared to monospecies biofilms (with the fold change being at least two).
In the present study, we focused on genes encoding proteins involved in biofilm formation,
antibiotic resistance, virulence, urease activity, transport, translation and general metabolism
of S. aureus Mu50 and S. epidermidis ET-024 (Table 1).
For both S. aureus Mu50 and S. epidermidis ET-024, genes involved in PIA production
(icaABCD) were expressed (but no significant differences were observed between gene expres-
sion levels in dual species biofilms compared to monospecies biofilms). Also, genes known to
be involved in PIA-independent biofilm formation (i.e. protein adhesion-associated biofilm
formation) were expressed by both S. aureus Mu50 (e.g. bap) and S. epidermidis ET-024 (e.g.
aap, bhp), but no significant differences in gene expression levels were observed when dual
species biofilms were compared to monospecies biofilms. To investigate the potential role of
Dual species biofilms of S. aureus and S. epidermidis
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Fig 1. The metabolic activity in single and dual species biofilms of S. aureus and S. epidermidis. The
fluorescence is normalized to the number (log10)of CFU per biofilm. Three biological replicates were included
and each experiment was repeated at least 6 times per biological replicate. Standard error mean (SEM; error
bars) was calculated for all conditions. A: The metabolic activity in single and dual species biofilms formed by
S. epidermidis ET isolates (ET-024, ET-059, ET-107, ET-130 and ET-167) and S. aureus reference strains
(Mu50, LMG 8224, LMG 10147, Newbould605 and ATCC 6568P). 1: p < 0.01, compared to S. aureus Mu50;
2: p < 0.01, compared to S. aureus LMG 8224; 3: p < 0.01, compared to S. aureus LMG 10147; 4: p < 0.01,
compared to S. aureus Newbould; 5: p < 0.01, compared to S. aureus JE2; 6: p < 0.01, compared to S. aureus
ATCC 6538P. B-E: The metabolic activity in single and dual species biofilms formed by S. aureus ET isolates
(ET-058, ET-106, ET-131 and ET-181), S. epidermidis ET isolates (ET-024, ET-059, ET-107, ET-130 and ET-
167). *: both S. epidermidis and S. aureus isolates were obtained from the same ET biofilm. ˚; p < 0.01,
compared to S. aureus ET-058 (Fig 1B), S. aureus ET-106 (Fig 1C), S. aureus ET-131 (Fig 1D) and S. aureus
ET-181 (Fig 1E), respectively.
doi:10.1371/journal.pone.0172700.g001
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Table 1. List of selected S. epidermidis ET-024 and S. aureus Mu50 genes which are differentially (indicated by “fold change”) expressed in dual
species biofilms compared to monospecies biofilms.
Gene Locus_tag Gene function Fold
change
p *
S. aureus Mu50
Virulence-
associated
spa SAV_RS00690 Immunoglobulin G binding protein A 3.92 + 0.21 0.00
dps SAV_RS11695 Dps general stress protein 20U 2.39 + 0.18 0.01
splF SAV_RS09715 Serine like protease F 2.38 + 0.22 0.00
Urease
ureA SAV_RS12475 Urease subunit gamma -2.59
+ 0.09
0.00
ureB SAV_RS12480 Urease subunit beta -2.61
+ 0.05
0.00
ureC SAV_RS12485 Urease subunit alpha -3.98
+ 0.08
0.00
ureD SAV_RS12505 Urease accessory protein UreD -5.09
+ 0.11
0.00
ureE SAV_RS12490 Urease accessory protein UreE -5.97
+ 0.08
0.00
ureF SAV_RS12495 Urease accessory protein UreF -2.00
+ 0.07
0.01
ureG SAV_RS12500 Urease accessory protein UreG -2.00 +0.19 0.01
Translation
SAVrRNA11 SAV_RS11260 5S ribosomal RNA -2.91
+ 0.27
0.00
SAVrRNA03 SAV_RS02630 5S ribosomal RNA -2.94
+ 0.27
0.00
SAVrRNA04 SAV_RS02845 5S ribosomal RNA -3.93
+ 0.17
0.00
SAVrRNA14 SAV_RS11835 5S ribosomal RNA -4.37
+ 0.18
0.00
SerS SAV_RS00190 Seryl-tRNA synthase -2.00
+ 0.19
0.00
Transporters
SAV1604 SAV_RS08625 Transmembrane transport protein -2.48
+ 0.07
0.00
lacF SAV_RS11985 PTS system lactose-specific transporter subunit IIA -2.62
+ 0.23
0.01
kdpA SAV_RS11365 Potassium-transporting ATPase subunit A -2.74
+ 0.22
0.00
SAV0330 SAV_RS01835 Sugar-specific PTS component EIIB -2.96
+ 0.08
0.00
SAV2253 SAV_RS12290 Xanthine/uracil permease family protein -2.00
+ 0.14
0.00
ulaA SAV_RS01830 PTS system ascorbate-specific transporter subunit IIC -2.86
+ 0.05
0.00
kdpB (SCCmec) SAV_RS00495 Potassium-transporting ATPase subunit B -3.19
+ 0.23
0.00
truncated-kdpA SAV_RS00490 Potassium-transporting ATPase subunit A -3.25
+ 0.20
0.00
Metabolism
(Continued )
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Table 1. (Continued)
Gene Locus_tag Gene function Fold
change
p *
lctE SAV_RS01365 L-lactate dehydrogenase -2.16
+ 0.20
0.00
SAV1606 SAV_RS08635 Acetyl-CoA carboxylase -2.17
+ 0.01
0.00
lacD SAV_RS11990 Tagatose 1,6-diphosphate aldolase -2.21
+ 0.19
lacC SAV_RS11995 Tagatose-6-phosphate kinase -2.41
+ 0.20
0.00
lacB SAV_RS12000 Galactose-6-phosphate isomerase subunit LacB -2.80
+ 0.25
0.00
pflB SAV_RS01275 Formate acetyltransferase -2.61
+ 0.08
0.00
purD SAV_RS05790 Phosphoribosylamine-glycine ligase -2.93
+ 0.13
0.00
purC SAV_RS05750 Phosphoribosylaminoimidazole-succinocarboxamide synthase -2.97
+ 0.17
0.00
purK SAV_RS05745 Phosphoribosylaminoimidazole carboxylase ATPase subunit -2.98
+ 0.16
0.00
purH SAV_RS05785 Bifunctional phosphoribosylaminoimidazolecarboxamide
formyltransferase/IMP cyclohydrolase
-3.83
+ 0.12
0.00
purF SAV_RS05770 Amidophosphoribosyltransferase -3.91
+ 0.15
0.00
purM SAV_RS05775 Phosphoribosylaminoimidazole synthetase -4.08
+ 0.13
0.00
SAV1064 SAV_RS05740 Phosphoribosylaminoimidazole carboxylase -3.72
+ 0.18
0.00
purQ SAV_RS05760 Phosphoribosylformylglycinamidine synthase I -4.59
+ 0.13
0.00
purL SAV_RS05765 Phosphoribosylformylglycinamidine synthase II -4.78
+ 0.12
0.00
purN SAV_RS05780 Phosphoribosylglycinamidine formyltransferase -4.81
+ 0.11
0.00
arcA SAV_RS14400 Arginine deiminase -3.10
+ 0.08
0.00
Various
SAV2401 SAV_RS13070 NirR protein -3.81
+ 0.07
0.00
S. epidermidis
ET-024
Antibiotic
resistance
aacA SERP-RS07950 6’aminoglycoside N-acetyltransferase 104.22
+ 10.37
0.00
ermA-1 SERP_RS06035 Erythromycine resistance 269.53
+ 25.11
0.00
ermA-2 SERP_RS06625 Erythromycine resistance 219.69
+ 20.55
0.00
ermA-3 SERP_RS12280 Erythromycine resistance 240.62
+ 21.19
0.00
mecA SERP_RS12330 Penicillin-binding protein 2’ 60.54
+ 5.64
0.00
Urease
(Continued )
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eDNA production in biofilm formation, we took a closer look at the expression of lrgAB and
atlE genes–while these genes are expressed, no significant differences in gene expression levels
Table 1. (Continued)
Gene Locus_tag Gene function Fold
change
p *
ureA SERP_RS09370 Urease subunit gamma -2.55
+ 0.41
0.01
ureB SERP_RS09375 Urease subunit beta -2.59
+ 0.46
0.01
ureC SERP_RS09380 Urease subunit alpha -2.65
+ 0.40
0.01
ureD SERP_RS09400 Urease accessory protein UreD -2.16
+ 0.13
0.01
ureE SERP_RS09385 Urease accessory protein UreE -2.30
+ 0.26
0.01
ureF SERP_RS09390 Urease accessory protein UreF -2.20
+ 0.16
0.01
Transporters
lacE SERP_RS08985 PTS system, lactose-specific IIBC components -2.45
+ 0.18
0.00
lacF SERP_RS08990 PTS system, lactose-specific IIA component -3.86
+ 0.14
0.00
arcD SERP_RS11080 Arginine/ornithine antiporter -2.55
+ 0.19
0.00
Metabolism
lacA SERP_RS09010 Galactose-6-phosphate isomerase subunit LacA -3.35
+ 0.17
0.00
lacB SERP_RS09005 Galactose-6-phosphate isomerase subunit LacB -2.82
+ 0.17
0.00
lacC SERP_RS09000 Tagatose-6-phosphate kinase -2.91
+ 0.18
0.00
lacD SERP_RS08995 Tagatose-1,6-diphosphate aldolase -3.16
+ 0.16
0.00
Various
SERP0736 SERP_RS03730 Phenol soluble modulin beta 1 -2.89
+ 0.17
0.00
SERP0737 SERP_RS03735 Phenol soluble modulin beta 1 -2.69
+ 0.20
0.00
SERP0738 SERP_RS03740 Phenol soluble modulin beta 1 -4.38
+ 0.22
0.00
SERP0739 SERP_RS03745 Phenol soluble modulin beta 1 -2.31
+ 0.21
0.00
SERP0371 SERP_RS01980 exsD protein -2.72
+ 0.12
0.01
SERP0996 SERP_RS04970 Carboxyl-terminal protease -2.29
+ 0.17
0.00
sspB SERP_RS11735 Cysteine protease precursor SspB -2.72
+ 0.06
0.00
sspC SERP_RS11740 sspC protein -3.25
+ 0.08
0.00
-: the minus sign indicates that there is a fold decrease
*: the p value was calculated using edgeR statistics (CLC Genomics Workbench 8.5.1) and statistical significance was defined as a p value smaller than
0.01. Three biological repeats were incorporated in the RNA-Seq experiment.
doi:10.1371/journal.pone.0172700.t001
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were observed in dual species biofilms compared to single species biofilms. However, in order
to decipher the exact mechanism of single and dual biofilm formation of S. aureus Mu50 and
S. epidermidis ET-024, more profound analyses are indispensable.
For S. epidermidis ET-024, a significant upregulation (p< 0.01) of genes encoding resis-
tance to methicillin (mecA; 60.5 fold), aminoglycosides (aacA; 104.2 fold) and erythromycin
(ermA-1, ermA-2, ermA-3; 219.7 to 269.5 fold) was observed in dual species biofilms compared
to monospecies biofilms. Six of the 7 S. epidermidis ET-024 urease genes (ureABCDEF) were
significantly downregulated (-2.2 to -2.7 fold) in dual species biofilms. Other significantly
downregulated genes in dual species biofilms included genes encoding transporters (lacEF,
-2.5 to -3.7 fold; arcD, -2.6 fold), genes encoding proteins involved in metabolism (lacABCD,-
2.8 to -3.4 fold) and various other genes (encoding e.g. phenol soluble modulins and proteases)
(Table 1).
For S. aureus Mu50, genes encoding virulence-associated proteins were significantly
(p< 0.01) upregulated in dual species biofilms compared to monospecies biofilms: spa (3.9
fold), splF (2.4 fold) and dps (2.4 fold). All S. aureus Mu50 urease genes were significantly
downregulated (-2.0 to -6.0 fold) in dual species biofilms compared to monospecies biofilms.
Also, S. aureus Mu50 genes encoding transporters (e.g. lacF, -2.6 fold; ulaA, -2.9 fold), genes
encoding proteins involved in metabolism (e.g. purH, -3.8 fold) and genes encoding factors
involved in translation were significantly less expressed in dual species biofilms compared to
monospecies biofilms.
Subsequently we set out experiments to confirm these RNA-Seq based observations with
qPCR. Prior to qPCR analyses, suitable reference genes for normalization were selected. For S.
aureus Mu50, the expression of reference genes fabD, gyrA, proC, pyk, rho and tpi was evaluated.
Based on initial testing, reference genes fabD and rho were selected and their gene expression
values were used to normalize the expression values of S. aureus Mu50 urease genes (Fig A in S1
File). For S. epidermidis ET-024, the expression of 7 potential reference genes was investigated
(Fig B in S1 File). Based on initial testing, reference genes aroE, gmk, folA and hsp60 were selected
and their expression values were used to normalize the expression values of S. epidermidis ET-
024 urease genes. For both strains, RNA-Seq analysis confirmed that the expression of the
selected reference genes did not differ between single and dual species biofilms.
There was significantly less expression of ureABCDEFG genes of S. aureus Mu50 in dual
species biofilms compared to monospecies biofilms and the fold change varied from—1.7
(ureA) to -4.2 (ureE) (Fig 2); this difference is apparently biofilm-specific, as there were no sig-
nificant differences in urease gene expression of S. aureus Mu50 in dual species planktonic cul-
tures compared to a S. aureus Mu50 monocultures (Fig 2).
For S. epidermidis ET-024, there were no significant differences in the expression of the ure-
ase genes in dual species biofilms compared to monospecies biofilms and the same was true
for planktonic cultures (Fig 2).
Urease activity in single and dual species biofilms
In order to further substantiate the results of the transcriptomics analysis, urease activity in
single and dual species biofilms was determined. In order to allow comparing data between
different biofilms, the urease activity (units urease/L) was normalized to the number of CFU
per biofilm (Table D in S1 File). After 24 hours of incubation, urease activity in dual species
biofilms of S. aureus Mu50 and S. epidermidis ET-024 biofilms was significantly lower than the
activity in S. aureus Mu50 biofilms but similar to the activity in S. epidermidis ET-024 mono-
species biofilms (Fig 3A). Also, urease activity in dual species biofilms formed by S. epidermidis
ET isolates (i.e. ET-024, ET-059, ET-107, ET-130 and ET-167) and S. aureus reference strains
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(i.e. Mu50, LMG 8224, LMG 10147, Newbould 305, JE2 and ATCC 6538P) was significantly
lower than the activity in monospecies biofilms formed by S. aureus reference strains (Fig 3A).
However, urease activity in dual species biofilms of S. epidermidis ET isolates and S. aureus ref-
erence strains was similar to urease activity in monospecies biofilms of S. epidermidis ET iso-
lates. Also, urease activity in biofilms formed by various other S. aureus (ET-058, ET-106,
ET-131 and ET-181) and S. epidermidis (ET-059, ET-107, ET-130 and ET-167) isolates, all
obtained from ET biofilms, was investigated (Fig 3B–3E). Urease activity was significantly
lower in dual species biofilms formed by S. aureus ET isolates and S. epidermidis ET isolates
compared to the activity in biofilms formed by S. aureus ET isolates. However, this effect was
not observed when S. aureus and S. epidermidis isolates originated from the same ET biofilm,
e.g. the urease activity in dual species biofilms formed by S. aureus ET-058 and S. epidermidis
ET-059 was similar to the urease activity in S. aureus ET-058 monospecies biofilms (Fig 3B).
Also, the urease activity in S. epidermidis ET monospecies biofilms and dual species biofilms
formed by S. aureus ET isolates and S. epidermidis ET isolates is similar.
The effect of antibiotics on single and dual species biofilms of S. aureus
Mu50 and S. epidermidis ET-024
RNA-Seq analysis showed that the S. epidermidis ET-024 genes encoding oxacillin, erythromycin
and tobramycin resistance were significantly upregulated in dual species biofilms. Therefore, we
exposed single and dual species biofilms of S. aureus Mu50 and S. epidermidis ET-024 to these
antibiotics. Prior to the experiments, the MIC of oxacillin, erythromycin and tobramycin for S.
aureus Mu50 and S. epidermidis ET-024 was determined. For S. epidermidis ET-024, the MIC of
oxacillin was 0.5 μg/ml, the MIC of erythromycin was 0.25 μg/ml and the MIC of tobramycin
was 2 μg/ml. The MICs for S. aureus Mu50 were higher: MIC of oxacillin was> 64 μg/ml, MIC
of erythromycin was> 128 μg/ml and MIC of tobramycin was 128 μg/ml.
Fig 2. The fold change (determined by qPCR) in urease gene expression of S. aureus Mu50 and S.
epidermidis ET-024 in dual species biofilms and dual species planktonic cultures compared to
monospecies biofilms (BF) and monospecies cultures (PL) (normalized by the expression values of
selected reference genes), respectively. Three biological replicates were included and each experiment was
repeated twice per biological replicate. SEM (error bars) was calculated for all conditions. *: p < 0.01. BF: biofilm;
PL: planktonic.
doi:10.1371/journal.pone.0172700.g002
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Single and dual species biofilms of S. epidermidis ET-024 and S. aureus Mu50 were exposed
to antibiotics for 20 hours, after 4 hours of incubation. The number of CFU/biofilm recovered
after treatment did not differ between dual species biofilms and S. aureus Mu50 biofilms when
biofilms were exposed to the antibiotics tested (Fig 4). In contrast, significantly more S. epider-
midis ET-024 cells survived treatment when in a dual species biofilm than when in a monospe-
cies biofilm (Fig 4).
Virulence in a C. elegans infection model
Prior to the experiments, different test conditions were evaluated (S1 File).We evaluated the
survival of nematodes when infected with S. aureus Mu50 S. aureus JE2 (the wild-type strain
used for creating the NARSA mutants) and observed no significant difference in survival (48
hours p.i.) (Table 2). Similarly, survival rates were comparable following infection with S.
aureus Mu50 and S. epidermidis ET-024 on the one hand and S. aureus JE2 and S. epidermidis
ET-024 on the other.
C. elegans were subsequently infected with NARSA mutants (lacking functional spa, splF or
dps genes) together with S. epidermidis ET-024 and a significant increase in survival was
observed compared to co-infection with S. aureus JE2 and S. epidermidis ET-024 (Table 2).
We also determined the number of staphylococcal CFU/nematode after (co-)infection; no
significant differences (p> 0.01) in number of CFU/nematode were observed in the different
test conditions (Table 2).
Discussion
Both S. aureus and S. epidermidis are often isolated from biofilm infections that are related to
the presence of indwelling medical devices [24–26]. Different interactions between these two
species have been described [39,44] and in the present study we investigated the mutual effect
of S. epidermidis and S. aureus in dual species biofilms.
Our results suggest that the presence of S. epidermidis in dual species biofilms with S. aureus
leads to slow-down of metabolism. Using a resazurin-based assay, we observed significantly
less metabolic activity in dual species biofilms of S. aureus and S. epidermidis compared to S.
aureus monospecies biofilms. Subsequently, lesser acids are produced; the pH in dual species
biofilms was significantly higher than in S. aureus Mu50 monospecies biofilms, while the pH
of dual species biofilms and S. epidermidis ET-024 biofilms were virtually identical (after 24
hours of incubation). So, there is less need for urease activity to balance the low pH. The tran-
scriptome analysis showed that all S. aureus Mu50 urease genes were significantly downregu-
lated in dual species biofilms compared to monospecies Mu50 biofilms. Also, there was lower
urease activity in mixed biofilms. For S. epidermidis ET-024, gene expression data (qPCR) indi-
cate that there is no significant difference in urease gene expression in dual species biofilms
compared to monospecies biofilms. This effect was not observed with S. epidermidis and S.
Fig 3. The urease activity in single and dual species biofilms of S. aureus and S. epidermidis (units urease/L normalized to
the number (log10) of CFU per biofilm). Three biological replicates were included and each experiment was repeated at least 6
times per biological replicate. Standard error mean (SEM; error bars) was calculated for all conditions. A: The urease activity in single
and dual species biofilms formed by S. epidermidis ET isolates (ET-024, ET-059, ET-107, ET-130 and ET-167) and S. aureus
reference strains (Mu50, LMG 8224, LMG 10147, Newbould605 and ATCC 6568P). 1: p < 0.01, compared to S. aureus Mu50; 2:
p < 0.01, compared to S. aureus LMG 8224; 3: p < 0.01, compared to S. aureus LMG 10147; 4: p < 0.01, compared to S. aureus
Newbould; 5: p < 0.01, compared to S. aureus JE2; 6: p < 0.01, compared to S. aureus ATCC 6538P. B-E: The urease activity in
single and dual species biofilms formed by S. aureus ET isolates (ET-058, ET-106, ET-131 and ET-181) and S. epidermidis ET
isolates (ET-024, ET-059, ET-107, ET-130 and ET-167). *: both S. epidermidis and S. aureus isolates were obtained from the same
ET biofilm. ˚; p < 0.01, compared to S. aureus ET-058 (Fig 1B), S. aureus ET-106 (Fig 1C), S. aureus ET-131 (Fig 1D) and S. aureus
ET-181 (Fig 1E), respectively.
doi:10.1371/journal.pone.0172700.g003
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aureus strains isolated from the same clinical sample, which suggests that these are somehow
“adapted” to each other. The mechanism underlying this adaptation is unknown and will
require further investigation. The effect of S. epidermidis on S. aureus was biofilm specific, as
no significant changes in urease and metabolic activity were observed in dual species plank-
tonic cultures. The exact mechanism by which S. epidermidis ET-024 influences the metabolic
activity of S. aureus Mu50 in dual species biofilms is still unclear. However, the inhibitory
effect of a less virulent commensal bacterium (e.g. S. epidermidis ET-024) on the metabolism
of a more virulent bacterium (e.g. S. aureus Mu50) in dual species biofilms may contribute to
the so-called colonization resistance [45].
RNA-Seq data showed no significant differences in expression levels of genes involved in
biofilm formation, suggesting that the underlying mechanisms of biofilm formation are not
different between single- and dual-species biofilms. RNA-Seq did show a significant upregula-
tion of S. epidermidis ET-024 genes encoding resistance to oxacillin, erythromycin and tobra-
mycin in dual species biofilms compared to monospecies biofilms. To investigate this, we
exposed biofilms to antibiotics in a concentration of 8 X the lowest MIC value (i.e. the MIC for
S. epidermidis ET-024). After treating dual species biofilms with oxacillin, erythromycin or
tobramycin, significantly more S. epidermidis ET-024 cells survived in dual species biofilms,
compared to monospecies biofilms, confirming that S. epidermidis ET-024 is less susceptible to
antibiotics in a dual species biofilm than in a monospecies biofilm. It is tempting to suggest
Fig 4. The number of S. epidermidis ET-024 and S. aureus Mu50 cells (log10 CFU/biofilm) in single and dual species biofilms after oxacillin (4 μg/
ml), erythromycin (2 μg/ml) and tobramycin (16 μg/ml) treatments. Three biological replicates were included and each experiment was repeated twice
per biological replicate. SEM (error bars) was calculated for all conditions.
doi:10.1371/journal.pone.0172700.g004
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that dual species biofilm infections are harder to treat than single species. Regardless, the
mechanism(s) involved remain to be elucidated.
For S. aureus Mu50, we observed a significant upregulation of virulence-associated genes
(spa, splF and dps) in dual species biofilms and this was further examined using a C. elegans
infection assay. This model system is well-suited to investigate the contribution of specific
gene products to virulence [46,47]. NARSA transposon mutants lacking a functional spa, splF
or dps gene were used to infect C. elegans. The survival of C. elegans significantly increased
when nematodes were infected with S. epidermidis ET-024 together with NE286 (lacking func-
tional spa), NE1764 (lacking functional splF) or NE1929 (lacking functional dps) compared to
infection with S. epidermidis ET-024 and wild-type S. aureus JE2.
Our results demonstrated that in dual species biofilms of S. aureus Mu50 and S. epidermidis
ET-024 genes involved in metabolism, urease activity, antibiotic resistance and virulence are
differently expressed compared to monospecies biofilms, and that these differences in expres-
sion lead to profound differences in physiology.
A better understanding of these interactions could be key to develop more effective
approaches to treat these dual species biofilm infections.
Supporting information
S1 File. All supplementary data, including data on expression stability of reference genes
for qPCR, biofilm forming capacities of all strains investigated, and results of preliminary
tests with C. elegans.
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NE286 (lacking functional spa) 80.3 ± 3.8 4.79 ± 0.19
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S. aureus Mu50 + S. epidermidis ET-
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49.2 ± 7.7 4.21 ± 0.21 (S. aureus)/ 3.68 ± 0.15 (S.
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